Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Creo Medical Group PLC

CREO.L ✗ NOT COMPLIANTFree checks used up today ☆ Track — members

LSE · Healthcare · Medical Equipment, Supplies & Distribution ·

UK Micro Cap Analyst: STRONG BUY

Last Close

$0.15

▲ +0.00%

Market Cap $68.33M · Vol 218.49K

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$68.33M

Micro Cap

Div Yield

N/A

EPS Growth

-344.15%

YoY

RSI (14)

88.89

Momentum

Beta

1.69

vs Market

52W High

$0.25

39.20% below

52W Low

$0.13

21.15% above

Volume

218.49K

Avg 901.63K

P/B

0.82

Price-to-book

ROE

7.79%

Return on equity

Free Float

93.06%

Public shares

Shariah Compliance8 STANDARDS

✗ Creo Medical Group PLC (CREO.L) stock is currently not Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CREO.L pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.11%

+9.38%

-14.15%

-12.50%

YTD

+14.90%

+1.11%

-61.48%

-92.42%

Financials & Valuation

TTM · Annual

Total Revenue	$8.08M
Net Income	$-23,577,597.00
Revenue Growth (YoY)	+45.45%
Gross Margin	40.00%
Operating Margin	-325.00%
Net Profit Margin	-291.67%
ROE	7.79%
ROA · ROIC	-28.20% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	6.81
P/B	0.82
P/FCF	N/A
EPS Growth	-344.15%
Outstanding Shares	449.14M

Technical Indicators

50-Day SMA	$0.16
200-Day SMA	$0.17
RSI (14)	88.89
Beta	1.69
52-Week High	$0.25
52-Week Low	$0.13

Volume Today	218.49K
Avg Daily Volume (30D)	901.63K
Relative Volume	0.24x
Volatility (10D)	21.57
Volatility (30D)	48.07
Free Float	93.06%

Analyst Consensus

STRONG BUY

Current Price $0.15

Mean Target $0.73

52W Low$0.13 52W High$0.25

Current

Target

$0.13 $0.25

Current Analyst target

+379.36% upside potential · 2 analysts

Identifiers

ExchangeLSE

FIGIBBG00FF47ZW1

ISINGB00BZ1BLL44

CountryUK

Sub-IndustryMedical Equipment

Earnings DateMay 20, 2027

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

PEN Penumbra, Inc. -0.94% GETI B.ST Getinge publ AB +1.57% 7747.T ASAHI INTECC CO., LTD. +0.85% 688617.SS APT Medical Inc -0.29% MMED MiniMed Group Inc -5.04%

Company Profile

Creo Medical Group plc is a medical device company. The Company is focused on the development and commercialization of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy. It is engaged in the research, development and distribution of electrosurgical medical devices relating to the field of surgical endoscopy. The Company has developed the CROMA powered by Kamaptive full-spectrum adaptive technology, which provides optimized surgical capability and patient outcomes. The Kamaptive is a seamless, intuitive integration of multi-modal energy sources. Its CROMA delivers bipolar radiofrequency (RF) energy for precise localized cutting and focused high frequency microwave (MW) energy for controlled coagulation and ablation via a single accessory port. This technology, combined with its range of patented electrosurgical devices, is designed to provide clinicians with flexible, accurate and controlled clinical solutions.